AKT1 and glioblastoma: Tubeimoside-I (TBMS1), a saponin from traditional Chinese medicine, can downregulate the expression of p-PI3K, p-AKT (Ser473), p-mTOR (Ser2481), and p-p65(Ser536) in GBM cells, and enhance the therapeutic effect of TMZ [142].